Contact-free monitoring experts from EarlySense have managed to secure $20 million in a funding round led by Samsung Ventures, with participation of Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber. The venture arm of the Korean giant provided half of the sum, which will allow EarlySense to continue its commercial expansion and to further move its solutions into the home-medical and consumer markets.

“EarlySense has developed and brought to market a unique, breakthrough technology that will improve the lives of consumers through health parameter sensing and monitoring. This technology, based on algorithms, analytics, and smart Health/IT capabilities, has been commercialized in the professional healthcare market over the past few years. This has built powerful clinical and market validation,” said Gonzalo Martinez de Azagra, Head of Samsung Ventures Israel. “Our investment is evidence of our belief in the need to bring sensors to hundreds of millions of consumers and we will do all that is in our hands to contribute to EarlySense’s accelerated growth.”

Investors expect that EarlySense continues to make excellent progress in supplying hospitals and long term care facilities with patient monitoring and management systems that offer tremendous value both clinically and economically.